What Is Methylmalonic Acid (MMA)? Normal vs Optimal Range Explained

Standard labs flag MMA only above 0.4 µmol/L, but functional B12 deficiency begins at lower thresholds. MMA accumulates because B12 is the required cofactor for methylmalonyl-CoA mutase—the enzyme that converts methylmalonyl-CoA into succinyl-CoA in the mitochondria. When B12 is insufficient, this conversion stalls and MMA builds up in the bloodstream. The CTD maps over 890 gene–chemical interactions for cobalamin (B12) and its metabolic pathways, confirming that even modest B12 shortfalls impair this critical mitochondrial enzyme. An MMA of 0.30–0.39 µmol/L sits within the lab normal range but already indicates that B12 is not reaching cells in adequate quantities—your mitochondrial energy metabolism is measurably compromised even though the standard lab report says everything is fine.

The clinical significance of MMA lies in its ability to unmask hidden B12 deficiency that serum B12 testing misses entirely. Serum B12 measures total circulating B12, including inactive forms bound to haptocorrin that your cells cannot use. A patient with a serum B12 of 300 pg/mL—well within the lab normal range—can still have an elevated MMA proving their cells are B12-starved. The FAERS database records over 9,400 adverse event reports linking metformin to B12 depletion, yet most prescribers monitor only serum B12, not MMA. This means millions of metformin users with functional B12 deficiency go undetected because the wrong test is being ordered. PPI users face the same diagnostic blind spot, as long-term acid suppression impairs B12 liberation from food.

Keeping MMA below 0.27 µmol/L confirms that B12 is reaching your cells and that methylmalonyl-CoA mutase is functioning optimally. PubMed indexes over 3,800 publications on MMA as a diagnostic marker for B12 status, consistently establishing it as superior to serum B12 for detecting subclinical deficiency. One important caveat: kidney disease independently elevates MMA because the kidneys excrete it—patients with impaired renal function need MMA interpreted alongside creatinine and eGFR. In people with normal kidney function, however, an elevated MMA above 0.27 µmol/L is a reliable, specific confirmation of functional B12 deficiency that warrants treatment, regardless of what the serum B12 number shows.